AXGN

AXGN

USD

Axogen Inc. Common Stock

$23.770+0.710 (3.079%)

السعر في الوقت الحقيقي

Healthcare
الأجهزة الطبية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$23.060

الأعلى

$23.830

الأدنى

$22.920

الحجم

0.27M

أساسيات الشركة

القيمة السوقية

1.1B

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

1.10M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $9.22الحالي $23.770الأعلى $23.83

أخبار ذات صلة

GlobeNewswire

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

عرض المزيد
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26

HC Wainwright & Co. analyst Yi Chen maintains Axogen with a Buy and raises the price target from $25 to $26.

عرض المزيد
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $26
Analyst Upgrades

Raymond James Maintains Outperform on Axogen, Raises Price Target to $27

Raymond James analyst Jayson Bedford maintains Axogen with a Outperform and raises the price target from $20 to $27.

عرض المزيد
Raymond James Maintains Outperform on Axogen, Raises Price Target to $27
Analyst Upgrades

Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27

Canaccord Genuity analyst Caitlin Cronin maintains Axogen with a Buy and raises the price target from $24 to $27.

عرض المزيد
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $27
Analyst Upgrades

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34

Citizens analyst David Turkaly maintains Axogen with a Market Outperform and raises the price target from $26 to $34.

عرض المزيد
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $34
GlobeNewswire

Axogen, Inc. Reports Third Quarter 2025 Financial Results

ALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

GlobeNewswire

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025

ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.